Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively. Full Year 2025 target total global revenue of appr ...
Typical acute hepatitis A virus (HAV ... to rule out HAV infection in the case of IgM detection without typical symptoms or biochemical abnormalities or in the case of weak epidemiological ...